Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes (Review)

  • Authors:
    • Yingqiu Xie
    • Sanzhar Naizabekov
    • Zhanlin Chen
    • Tursonjan Tokay
  • View Affiliations

  • Published online on: May 26, 2016     https://doi.org/10.3892/ol.2016.4636
  • Pages: 375-378
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

An increasing amount of evidence has shown that tumor suppressors can become oncogenes, or vice versa, but the mechanism behind this is unclear. Recent findings have suggested that phosphatase and tensin homolog (PTEN) is one of the powerful switches for the conversion between tumor suppressors and oncogenes. PTEN regulates a number of cellular processes, including cell death and proliferation, through the phosphoinositide 3‑kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway. Furthermore, a number of studies have suggested that PTEN deletions may alter various functions of certain tumor suppressor and oncogenic proteins. The aim of the present review was to analyze specific cases driven by PTEN loss/AKT activation, including aberrant signaling pathways and novel drug targets for clinical application in personalized medicine. The findings illustrate how PTEN loss and/or AKT activation switches MDM2‑dependent p53 downregulation, and induces conversion between oncogene and tumor suppressor in enhancer of zeste homolog 2, BTB domain‑containing 7A, alternative reading frame 2, p27 and breast cancer 1, early onset, through multiple mechanisms. This review highlights the genetic basis of complex drug targets and provides insights into the rationale of precision cancer therapy.
View Figures
View References

Related Articles

Journal Cover

July-2016
Volume 12 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xie Y, Naizabekov S, Chen Z and Tokay T: Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes (Review). Oncol Lett 12: 375-378, 2016.
APA
Xie, Y., Naizabekov, S., Chen, Z., & Tokay, T. (2016). Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes (Review). Oncology Letters, 12, 375-378. https://doi.org/10.3892/ol.2016.4636
MLA
Xie, Y., Naizabekov, S., Chen, Z., Tokay, T."Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes (Review)". Oncology Letters 12.1 (2016): 375-378.
Chicago
Xie, Y., Naizabekov, S., Chen, Z., Tokay, T."Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes (Review)". Oncology Letters 12, no. 1 (2016): 375-378. https://doi.org/10.3892/ol.2016.4636